We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00052507
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : July 23, 2015
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University Health Network, Toronto